1-(1H-benzimidazol-2-yl)-N-butan-2-ylmethanimine;1-(1H-benzimidazol-2-yl)-N-cyclobutylmethanimine;1-(1H-benzimidazol-2-yl)-N-hexylmethanimine;N-butan-2-yl-1-(1-methylbenzimidazol-2-yl)methanimine;N-cyclobutyl-1-(4,7-diphenyl-1H-benzimidazol-2-yl)methanimine;1-(4,7-diphenyl-1H-benzimidazol-2-yl)-N-hexylmethanimine;1-(4,7-diphenyl-1H-benzimidazol-2-yl)-N-[[2-(trifluoromethyl)phenyl]methyl]methanimine;N-hexyl-1-(1-methyl-4,7-diphenylbenzimidazol-2-yl)methanimine;1-(1-methylbenzimidazol-2-yl)-N-(2-pyrrolidin-1-ylphenyl)methanimine

C175H181F3N28 — CID 158747726

IUPAC1-(1H-benzimidazol-2-yl)-N-butan-2-ylmethanimine;1-(1H-benzimidazol-2-yl)-N-cyclobutylmethanimine;1-(1H-benzimidazol-2-yl)-N-hexylmethanimine;N-butan-2-yl-1-(1-methylbenzimidazol-2-yl)methanimine;N-cyclobutyl-1-(4,7-diphenyl-1H-benzimidazol-2-yl)methanimine;1-(4,7-diphenyl-1H-benzimidazol-2-yl)-N-hexylmethanimine;1-(4,7-diphenyl-1H-benzimidazol-2-yl)-N-[[2-(trifluoromethyl)phenyl]methyl]methanimine;N-hexyl-1-(1-methyl-4,7-diphenylbenzimidazol-2-yl)methanimine;1-(1-methylbenzimidazol-2-yl)-N-(2-pyrrolidin-1-ylphenyl)methanimine
SMILESC(=N/C1CCC1)\c1nc2c(-c3ccccc3)ccc(-c3ccccc3)c2[nH]1.C(=N/C1CCC1)\c1nc2ccccc2[nH]1.CCC(C)/N=C/c1nc2ccccc2[nH]1.CCC(C)/N=C/c1nc2ccccc2n1C.CCCCCC/N=C/c1nc2c(-c3ccccc3)ccc(-c3ccccc3)c2[nH]1.CCCCCC/N=C/c1nc2c(-c3ccccc3)ccc(-c3ccccc3)c2n1C.CCCCCC/N=C/c1nc2ccccc2[nH]1.Cn1c(/C=N/c2ccccc2N2CCCC2)nc2ccccc21.FC(F)(F)c1ccccc1C/N=C/c1nc2c(-c3ccccc3)ccc(-c3ccccc3)c2[nH]1
InChIInChI=1S/C28H20F3N3.C27H29N3.C26H27N3.C24H21N3.C19H20N4.C14H19N3.C13H17N3.C12H13N3.C12H15N3/c29-28(30,31)24-14-8-7-13-21(24)17-32-18-25-33-26-22(19-9-3-1-4-10-19)15-16-23(27(26)34-25)20-11-5-2-6-12-20;1-3-4-5-12-19-28-20-25-29-26-23(21-13-8-6-9-14-21)17-18-24(27(26)30(25)2)22-15-10-7-11-16-22;1-2-3-4-11-18-27-19-24-28-25-22(20-12-7-5-8-13-20)16-17-23(26(25)29-24)21-14-9-6-10-15-21;1-3-8-17(9-4-1)20-14-15-21(18-10-5-2-6-11-18)24-23(20)26-22(27-24)16-25-19-12-7-13-19;1-22-17-10-4-3-9-16(17)21-19(22)14-20-15-8-2-5-11-18(15)23-12-6-7-13-23;1-2-3-4-7-10-15-11-14-16-12-8-5-6-9-13(12)17-14;1-4-10(2)14-9-13-15-11-7-5-6-8-12(11)16(13)3;1-2-7-11-10(6-1)14-12(15-11)8-13-9-4-3-5-9;1-3-9(2)13-8-12-14-10-6-4-5-7-11(10)15-12/h1-16,18H,17H2,(H,33,34);6-11,13-18,20H,3-5,12,19H2,1-2H3;5-10,12-17,19H,2-4,11,18H2,1H3,(H,28,29);1-6,8-11,14-16,19H,7,12-13H2,(H,26,27);2-5,8-11,14H,6-7,12-13H2,1H3;5-6,8-9,11H,2-4,7,10H2,1H3,(H,16,17);5-10H,4H2,1-3H3;1-2,6-9H,3-5H2,(H,14,15);4-9H,3H2,1-2H3,(H,14,15)/b32-18+;28-20+;27-19+;25-16+;20-14+;15-11+;14-9+;2*13-8+
InChIKeyINBXAGHCXNDADC-PSVXODBNSA-N
MW2733.56 g/mol
LogP42.80
Rot. Bonds42

About 1-(1H-benzimidazol-2-yl)-N-butan-2-ylmethanimine;1-(1H-benzimidazol-2-yl)-N-cyclobutylmethanimine;1-(1H-benzimidazol-2-yl)-N-hexylmethanimine;N-butan-2-yl-1-(1-methylbenzimidazol-2-yl)methanimine;N-cyclobutyl-1-(4,7-diphenyl-1H-benzimidazol-2-yl)methanimine;1-(4,7-diphenyl-1H-benzimidazol-2-yl)-N-hexylmethanimine;1-(4,7-diphenyl-1H-benzimidazol-2-yl)-N-[[2-(trifluoromethyl)phenyl]methyl]methanimine;N-hexyl-1-(1-methyl-4,7-diphenylbenzimidazol-2-yl)methanimine;1-(1-methylbenzimidazol-2-yl)-N-(2-pyrrolidin-1-ylphenyl)methanimine

1-(1H-benzimidazol-2-yl)-N-butan-2-ylmethanimine;1-(1H-benzimidazol-2-yl)-N-cyclobutylmethanimine;1-(1H-benzimidazol-2-yl)-N-hexylmethanimine;N-butan-2-yl-1-(1-methylbenzimidazol-2-yl)methanimine;N-cyclobutyl-1-(4,7-diphenyl-1H-benzimidazol-2-yl)methanimine;1-(4,7-diphenyl-1H-benzimidazol-2-yl)-N-hexylmethanimine;1-(4,7-diphenyl-1H-benzimidazol-2-yl)-N-[[2-(trifluoromethyl)phenyl]methyl]methanimine;N-hexyl-1-(1-methyl-4,7-diphenylbenzimidazol-2-yl)methanimine;1-(1-methylbenzimidazol-2-yl)-N-(2-pyrrolidin-1-ylphenyl)methanimine (PubChem CID 158747726) has the molecular formula C175H181F3N28 and a molecular weight of 2733.56 g/mol. Its IUPAC name is 1-(1H-benzimidazol-2-yl)-N-butan-2-ylmethanimine;1-(1H-benzimidazol-2-yl)-N-cyclobutylmethanimine;1-(1H-benzimidazol-2-yl)-N-hexylmethanimine;N-butan-2-yl-1-(1-methylbenzimidazol-2-yl)methanimine;N-cyclobutyl-1-(4,7-diphenyl-1H-benzimidazol-2-yl)methanimine;1-(4,7-diphenyl-1H-benzimidazol-2-yl)-N-hexylmethanimine;1-(4,7-diphenyl-1H-benzimidazol-2-yl)-N-[[2-(trifluoromethyl)phenyl]methyl]methanimine;N-hexyl-1-(1-methyl-4,7-diphenylbenzimidazol-2-yl)methanimine;1-(1-methylbenzimidazol-2-yl)-N-(2-pyrrolidin-1-ylphenyl)methanimine.

Molecular Properties

Compound Name1-(1H-benzimidazol-2-yl)-N-butan-2-ylmethanimine;1-(1H-benzimidazol-2-yl)-N-cyclobutylmethanimine;1-(1H-benzimidazol-2-yl)-N-hexylmethanimine;N-butan-2-yl-1-(1-methylbenzimidazol-2-yl)methanimine;N-cyclobutyl-1-(4,7-diphenyl-1H-benzimidazol-2-yl)methanimine;1-(4,7-diphenyl-1H-benzimidazol-2-yl)-N-hexylmethanimine;1-(4,7-diphenyl-1H-benzimidazol-2-yl)-N-[[2-(trifluoromethyl)phenyl]methyl]methanimine;N-hexyl-1-(1-methyl-4,7-diphenylbenzimidazol-2-yl)methanimine;1-(1-methylbenzimidazol-2-yl)-N-(2-pyrrolidin-1-ylphenyl)methanimine
PubChem CID158747726
Molecular FormulaC175H181F3N28
Molecular Weight2733.56 g/mol
Exact Mass2731.50
IUPAC Name1-(1H-benzimidazol-2-yl)-N-butan-2-ylmethanimine;1-(1H-benzimidazol-2-yl)-N-cyclobutylmethanimine;1-(1H-benzimidazol-2-yl)-N-hexylmethanimine;N-butan-2-yl-1-(1-methylbenzimidazol-2-yl)methanimine;N-cyclobutyl-1-(4,7-diphenyl-1H-benzimidazol-2-yl)methanimine;1-(4,7-diphenyl-1H-benzimidazol-2-yl)-N-hexylmethanimine;1-(4,7-diphenyl-1H-benzimidazol-2-yl)-N-[[2-(trifluoromethyl)phenyl]methyl]methanimine;N-hexyl-1-(1-methyl-4,7-diphenylbenzimidazol-2-yl)methanimine;1-(1-methylbenzimidazol-2-yl)-N-(2-pyrrolidin-1-ylphenyl)methanimine
SMILESC(=N/C1CCC1)\c1nc2c(-c3ccccc3)ccc(-c3ccccc3)c2[nH]1.C(=N/C1CCC1)\c1nc2ccccc2[nH]1.CCC(C)/N=C/c1nc2ccccc2[nH]1.CCC(C)/N=C/c1nc2ccccc2n1C.CCCCCC/N=C/c1nc2c(-c3ccccc3)ccc(-c3ccccc3)c2[nH]1.CCCCCC/N=C/c1nc2c(-c3ccccc3)ccc(-c3ccccc3)c2n1C.CCCCCC/N=C/c1nc2ccccc2[nH]1.Cn1c(/C=N/c2ccccc2N2CCCC2)nc2ccccc21.FC(F)(F)c1ccccc1C/N=C/c1nc2c(-c3ccccc3)ccc(-c3ccccc3)c2[nH]1
InChIInChI=1S/C28H20F3N3.C27H29N3.C26H27N3.C24H21N3.C19H20N4.C14H19N3.C13H17N3.C12H13N3.C12H15N3/c29-28(30,31)24-14-8-7-13-21(24)17-32-18-25-33-26-22(19-9-3-1-4-10-19)15-16-23(27(26)34-25)20-11-5-2-6-12-20;1-3-4-5-12-19-28-20-25-29-26-23(21-13-8-6-9-14-21)17-18-24(27(26)30(25)2)22-15-10-7-11-16-22;1-2-3-4-11-18-27-19-24-28-25-22(20-12-7-5-8-13-20)16-17-23(26(25)29-24)21-14-9-6-10-15-21;1-3-8-17(9-4-1)20-14-15-21(18-10-5-2-6-11-18)24-23(20)26-22(27-24)16-25-19-12-7-13-19;1-22-17-10-4-3-9-16(17)21-19(22)14-20-15-8-2-5-11-18(15)23-12-6-7-13-23;1-2-3-4-7-10-15-11-14-16-12-8-5-6-9-13(12)17-14;1-4-10(2)14-9-13-15-11-7-5-6-8-12(11)16(13)3;1-2-7-11-10(6-1)14-12(15-11)8-13-9-4-3-5-9;1-3-9(2)13-8-12-14-10-6-4-5-7-11(10)15-12/h1-16,18H,17H2,(H,33,34);6-11,13-18,20H,3-5,12,19H2,1-2H3;5-10,12-17,19H,2-4,11,18H2,1H3,(H,28,29);1-6,8-11,14-16,19H,7,12-13H2,(H,26,27);2-5,8-11,14H,6-7,12-13H2,1H3;5-6,8-9,11H,2-4,7,10H2,1H3,(H,16,17);5-10H,4H2,1-3H3;1-2,6-9H,3-5H2,(H,14,15);4-9H,3H2,1-2H3,(H,14,15)/b32-18+;28-20+;27-19+;25-16+;20-14+;15-11+;14-9+;2*13-8+
InChIKeyINBXAGHCXNDADC-PSVXODBNSA-N
XLogP42.80
TPSA340.02 Ų
H-Bond Donors6
H-Bond Acceptors22
Rotatable Bonds42
Heavy Atoms206
Complexity—

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002733.56
LogP ≤ 542.80
H-Bond Donors ≤ 56
H-Bond Acceptors ≤ 1022

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'imine_1', 'substructure': 'N/A'}

Analyze 1-(1H-benzimidazol-2-yl)-N-butan-2-ylmethanimine;1-(1H-benzimidazol-2-yl)-N-cyclobutylmethanimine;1-(1H-benzimidazol-2-yl)-N-hexylmethanimine;N-butan-2-yl-1-(1-methylbenzimidazol-2-yl)methanimine;N-cyclobutyl-1-(4,7-diphenyl-1H-benzimidazol-2-yl)methanimine;1-(4,7-diphenyl-1H-benzimidazol-2-yl)-N-hexylmethanimine;1-(4,7-diphenyl-1H-benzimidazol-2-yl)-N-[[2-(trifluoromethyl)phenyl]methyl]methanimine;N-hexyl-1-(1-methyl-4,7-diphenylbenzimidazol-2-yl)methanimine;1-(1-methylbenzimidazol-2-yl)-N-(2-pyrrolidin-1-ylphenyl)methanimine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

N,N,N',N'-tetrakis[(6-methyl-1H-benzimidazol-2-yl)methyl]ethane-1,2-diamine
CID 335974
1-[[4-[2-(1H-imidazol-2-yl)phenyl]phenyl]methyl]-4-methyl-6-(1-methylbenzimidazol-2-yl)-2-propylbenzimidazole
CID 44563174
2,7-Bis[5-(4,5-dihydro-1H-imidazol-2-yl)-1H-benzimidazol-2-yl]-9H-carbazole
CID 135499479
[2-[4-[2-[4-[6-(pyrrolidine-1-carboximidoyl)-1H-benzimidazol-2-yl]phenyl]ethyl]phenyl]-3H-benzimidazol-5-yl]-pyrrolidin-1-ylmethanimine
CID 44565214
5,5'-[(2R,5R)-1-[3,5-Difluoro-4-[4-(4-fluorophenyl)-1-piperidinyl]phenyl]-2,5-pyrrolidinediyl]bis[6-fluoro-2-(2S)-2-pyrrolidinyl-1H-benzimidazole]
CID 66629958
1,2,4,5-Tetrakis(benzimidazol-2-yl)benzene
CID 78319297
1,3-Bis[bis(2-benzimidazolylmethyl)aminomethyl]benzol
CID 18767358
4-methyl-1-[3-(1-methylpiperidin-4-yl)propyl]-5-[5-methyl-4-[4-(trifluoromethyl)phenyl]-1H-imidazol-2-yl]benzimidazole
CID 42624347
7-[4-[2-[(2S)-4,4-difluoropyrrolidin-2-yl]-1H-imidazol-5-yl]phenyl]-2-[(2S)-pyrrolidin-2-yl]-3H-benzo[e]benzimidazole
CID 44187296
2-[(2S)-4,4-difluoropyrrolidin-2-yl]-7-[4-[2-[(2S)-pyrrolidin-2-yl]-1H-imidazol-5-yl]phenyl]-3H-benzo[e]benzimidazole
CID 44187297
2-[(2S)-4,4-difluoropyrrolidin-2-yl]-7-[4-[2-[(2S)-4,4-difluoropyrrolidin-2-yl]-1H-imidazol-5-yl]phenyl]-3H-benzo[e]benzimidazole
CID 57816536
6,6'-[(2R,5R)-1-(4-tert-butylphenyl)pyrrolidine-2,5-diyl]bis {5-fluoro-2-[(2S)-pyrrolidin-2-yl]-1H-benzimidazole}
CID 58226557

Frequently Asked Questions

What is the IUPAC name of 1-(1H-benzimidazol-2-yl)-N-butan-2-ylmethanimine;1-(1H-benzimidazol-2-yl)-N-cyclobutylmethanimine;1-(1H-benzimidazol-2-yl)-N-hexylmethanimine;N-butan-2-yl-1-(1-methylbenzimidazol-2-yl)methanimine;N-cyclobutyl-1-(4,7-diphenyl-1H-benzimidazol-2-yl)methanimine;1-(4,7-diphenyl-1H-benzimidazol-2-yl)-N-hexylmethanimine;1-(4,7-diphenyl-1H-benzimidazol-2-yl)-N-[[2-(trifluoromethyl)phenyl]methyl]methanimine;N-hexyl-1-(1-methyl-4,7-diphenylbenzimidazol-2-yl)methanimine;1-(1-methylbenzimidazol-2-yl)-N-(2-pyrrolidin-1-ylphenyl)methanimine?
The IUPAC name of 1-(1H-benzimidazol-2-yl)-N-butan-2-ylmethanimine;1-(1H-benzimidazol-2-yl)-N-cyclobutylmethanimine;1-(1H-benzimidazol-2-yl)-N-hexylmethanimine;N-butan-2-yl-1-(1-methylbenzimidazol-2-yl)methanimine;N-cyclobutyl-1-(4,7-diphenyl-1H-benzimidazol-2-yl)methanimine;1-(4,7-diphenyl-1H-benzimidazol-2-yl)-N-hexylmethanimine;1-(4,7-diphenyl-1H-benzimidazol-2-yl)-N-[[2-(trifluoromethyl)phenyl]methyl]methanimine;N-hexyl-1-(1-methyl-4,7-diphenylbenzimidazol-2-yl)methanimine;1-(1-methylbenzimidazol-2-yl)-N-(2-pyrrolidin-1-ylphenyl)methanimine (CID 158747726) is 1-(1H-benzimidazol-2-yl)-N-butan-2-ylmethanimine;1-(1H-benzimidazol-2-yl)-N-cyclobutylmethanimine;1-(1H-benzimidazol-2-yl)-N-hexylmethanimine;N-butan-2-yl-1-(1-methylbenzimidazol-2-yl)methanimine;N-cyclobutyl-1-(4,7-diphenyl-1H-benzimidazol-2-yl)methanimine;1-(4,7-diphenyl-1H-benzimidazol-2-yl)-N-hexylmethanimine;1-(4,7-diphenyl-1H-benzimidazol-2-yl)-N-[[2-(trifluoromethyl)phenyl]methyl]methanimine;N-hexyl-1-(1-methyl-4,7-diphenylbenzimidazol-2-yl)methanimine;1-(1-methylbenzimidazol-2-yl)-N-(2-pyrrolidin-1-ylphenyl)methanimine.
What is the SMILES notation for 1-(1H-benzimidazol-2-yl)-N-butan-2-ylmethanimine;1-(1H-benzimidazol-2-yl)-N-cyclobutylmethanimine;1-(1H-benzimidazol-2-yl)-N-hexylmethanimine;N-butan-2-yl-1-(1-methylbenzimidazol-2-yl)methanimine;N-cyclobutyl-1-(4,7-diphenyl-1H-benzimidazol-2-yl)methanimine;1-(4,7-diphenyl-1H-benzimidazol-2-yl)-N-hexylmethanimine;1-(4,7-diphenyl-1H-benzimidazol-2-yl)-N-[[2-(trifluoromethyl)phenyl]methyl]methanimine;N-hexyl-1-(1-methyl-4,7-diphenylbenzimidazol-2-yl)methanimine;1-(1-methylbenzimidazol-2-yl)-N-(2-pyrrolidin-1-ylphenyl)methanimine?
The canonical SMILES for 1-(1H-benzimidazol-2-yl)-N-butan-2-ylmethanimine;1-(1H-benzimidazol-2-yl)-N-cyclobutylmethanimine;1-(1H-benzimidazol-2-yl)-N-hexylmethanimine;N-butan-2-yl-1-(1-methylbenzimidazol-2-yl)methanimine;N-cyclobutyl-1-(4,7-diphenyl-1H-benzimidazol-2-yl)methanimine;1-(4,7-diphenyl-1H-benzimidazol-2-yl)-N-hexylmethanimine;1-(4,7-diphenyl-1H-benzimidazol-2-yl)-N-[[2-(trifluoromethyl)phenyl]methyl]methanimine;N-hexyl-1-(1-methyl-4,7-diphenylbenzimidazol-2-yl)methanimine;1-(1-methylbenzimidazol-2-yl)-N-(2-pyrrolidin-1-ylphenyl)methanimine is C(=N/C1CCC1)\c1nc2c(-c3ccccc3)ccc(-c3ccccc3)c2[nH]1.C(=N/C1CCC1)\c1nc2ccccc2[nH]1.CCC(C)/N=C/c1nc2ccccc2[nH]1.CCC(C)/N=C/c1nc2ccccc2n1C.CCCCCC/N=C/c1nc2c(-c3ccccc3)ccc(-c3ccccc3)c2[nH]1.CCCCCC/N=C/c1nc2c(-c3ccccc3)ccc(-c3ccccc3)c2n1C.CCCCCC/N=C/c1nc2ccccc2[nH]1.Cn1c(/C=N/c2ccccc2N2CCCC2)nc2ccccc21.FC(F)(F)c1ccccc1C/N=C/c1nc2c(-c3ccccc3)ccc(-c3ccccc3)c2[nH]1.
What is the InChIKey of 1-(1H-benzimidazol-2-yl)-N-butan-2-ylmethanimine;1-(1H-benzimidazol-2-yl)-N-cyclobutylmethanimine;1-(1H-benzimidazol-2-yl)-N-hexylmethanimine;N-butan-2-yl-1-(1-methylbenzimidazol-2-yl)methanimine;N-cyclobutyl-1-(4,7-diphenyl-1H-benzimidazol-2-yl)methanimine;1-(4,7-diphenyl-1H-benzimidazol-2-yl)-N-hexylmethanimine;1-(4,7-diphenyl-1H-benzimidazol-2-yl)-N-[[2-(trifluoromethyl)phenyl]methyl]methanimine;N-hexyl-1-(1-methyl-4,7-diphenylbenzimidazol-2-yl)methanimine;1-(1-methylbenzimidazol-2-yl)-N-(2-pyrrolidin-1-ylphenyl)methanimine?
The InChIKey is INBXAGHCXNDADC-PSVXODBNSA-N. The full InChI is InChI=1S/C28H20F3N3.C27H29N3.C26H27N3.C24H21N3.C19H20N4.C14H19N3.C13H17N3.C12H13N3.C12H15N3/c29-28(30,31)24-14-8-7-13-21(24)17-32-18-25-33-26-22(19-9-3-1-4-10-19)15-16-23(27(26)34-25)20-11-5-2-6-12-20;1-3-4-5-12-19-28-20-25-29-26-23(21-13-8-6-9-14-21)17-18-24(27(26)30(25)2)22-15-10-7-11-16-22;1-2-3-4-11-18-27-19-24-28-25-22(20-12-7-5-8-13-20)16-17-23(26(25)29-24)21-14-9-6-10-15-21;1-3-8-17(9-4-1)20-14-15-21(18-10-5-2-6-11-18)24-23(20)26-22(27-24)16-25-19-12-7-13-19;1-22-17-10-4-3-9-16(17)21-19(22)14-20-15-8-2-5-11-18(15)23-12-6-7-13-23;1-2-3-4-7-10-15-11-14-16-12-8-5-6-9-13(12)17-14;1-4-10(2)14-9-13-15-11-7-5-6-8-12(11)16(13)3;1-2-7-11-10(6-1)14-12(15-11)8-13-9-4-3-5-9;1-3-9(2)13-8-12-14-10-6-4-5-7-11(10)15-12/h1-16,18H,17H2,(H,33,34);6-11,13-18,20H,3-5,12,19H2,1-2H3;5-10,12-17,19H,2-4,11,18H2,1H3,(H,28,29);1-6,8-11,14-16,19H,7,12-13H2,(H,26,27);2-5,8-11,14H,6-7,12-13H2,1H3;5-6,8-9,11H,2-4,7,10H2,1H3,(H,16,17);5-10H,4H2,1-3H3;1-2,6-9H,3-5H2,(H,14,15);4-9H,3H2,1-2H3,(H,14,15)/b32-18+;28-20+;27-19+;25-16+;20-14+;15-11+;14-9+;2*13-8+.
What are the key properties of 1-(1H-benzimidazol-2-yl)-N-butan-2-ylmethanimine;1-(1H-benzimidazol-2-yl)-N-cyclobutylmethanimine;1-(1H-benzimidazol-2-yl)-N-hexylmethanimine;N-butan-2-yl-1-(1-methylbenzimidazol-2-yl)methanimine;N-cyclobutyl-1-(4,7-diphenyl-1H-benzimidazol-2-yl)methanimine;1-(4,7-diphenyl-1H-benzimidazol-2-yl)-N-hexylmethanimine;1-(4,7-diphenyl-1H-benzimidazol-2-yl)-N-[[2-(trifluoromethyl)phenyl]methyl]methanimine;N-hexyl-1-(1-methyl-4,7-diphenylbenzimidazol-2-yl)methanimine;1-(1-methylbenzimidazol-2-yl)-N-(2-pyrrolidin-1-ylphenyl)methanimine?
1-(1H-benzimidazol-2-yl)-N-butan-2-ylmethanimine;1-(1H-benzimidazol-2-yl)-N-cyclobutylmethanimine;1-(1H-benzimidazol-2-yl)-N-hexylmethanimine;N-butan-2-yl-1-(1-methylbenzimidazol-2-yl)methanimine;N-cyclobutyl-1-(4,7-diphenyl-1H-benzimidazol-2-yl)methanimine;1-(4,7-diphenyl-1H-benzimidazol-2-yl)-N-hexylmethanimine;1-(4,7-diphenyl-1H-benzimidazol-2-yl)-N-[[2-(trifluoromethyl)phenyl]methyl]methanimine;N-hexyl-1-(1-methyl-4,7-diphenylbenzimidazol-2-yl)methanimine;1-(1-methylbenzimidazol-2-yl)-N-(2-pyrrolidin-1-ylphenyl)methanimine has a molecular weight of 2733.56 g/mol, XLogP of 42.80, 42 rotatable bonds, 6 hydrogen bond donors, and 22 hydrogen bond acceptors.
Where does this data come from?
All data for 1-(1H-benzimidazol-2-yl)-N-butan-2-ylmethanimine;1-(1H-benzimidazol-2-yl)-N-cyclobutylmethanimine;1-(1H-benzimidazol-2-yl)-N-hexylmethanimine;N-butan-2-yl-1-(1-methylbenzimidazol-2-yl)methanimine;N-cyclobutyl-1-(4,7-diphenyl-1H-benzimidazol-2-yl)methanimine;1-(4,7-diphenyl-1H-benzimidazol-2-yl)-N-hexylmethanimine;1-(4,7-diphenyl-1H-benzimidazol-2-yl)-N-[[2-(trifluoromethyl)phenyl]methyl]methanimine;N-hexyl-1-(1-methyl-4,7-diphenylbenzimidazol-2-yl)methanimine;1-(1-methylbenzimidazol-2-yl)-N-(2-pyrrolidin-1-ylphenyl)methanimine is sourced from PubChem (CID 158747726), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).